A previous study reported that TAK-242 administration suppressed neutrophil infiltration in an imiquimod-induced psoriasis model8, so we considered that suppressing the innate immune system and infiltration of neutrophils by suppressing downstream of TLR4 could suppress this CHS response even in the CHS model. The gene discussed is LYST; the disease is psoriasis.